KUALA LUMPUR: Pharmaniaga Bhd’s unit has inked an agreement with the government to supply an additional six million doses of the Covid-19 vaccine.

       It said on Thursday its unit Pharmaniaga Lifescience Sdn Bhd (PLS) had signed the additional supply agreement to supply the “fill and finish” and imported finished product of the Covid-19 vaccine.

       Pharmaniaga said “fill and finish” means the vaccine manufactured by means of fill and finish, and packaged by PLS in vials ready for human use, for local distribution.

       “Imported finished product” refers the vaccine produced and manufactured by Sinovac in China.

       The supply agreement came into effect on Wednesday and shall continue until the delivery of the last batch of the product to the facilities.

       The agreement and collaboration will serve as a platform for the company to assist the nation in supplying the vaccine. It will also help Malaysia to achieve its targeted vaccination rate.